AHL Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$9.78M Buy
83,453
+26,330
+46% +$2.98M 0.15% 227
2017
Q3
$6.49M Sell
57,123
-3,517
-6% -$406K 0.12% 315
2017
Q2
$7.56M Sell
60,640
-36,443
-38% -$4.32M 0.16% 194
2017
Q1
$11.5M Buy
+97,083
New +$11M 0.25% 73
2016
Q4
Sell
-7,806
Closed -$985K 1200
2016
Q3
$985K Buy
7,806
+34
+0.4% +$4.2K 0.04% 605
2016
Q2
$909K Buy
7,772
+5,174
+199% +$586K 0.05% 460
2016
Q1
$269K Sell
2,598
-117
-4% -$11.3K 0.02% 683
2015
Q4
$270K Sell
2,715
-666
-20% -$65.2K 0.02% 638
2015
Q3
$308K Sell
3,381
-56,907
-94% -$5.7M 0.05% 552
2015
Q2
$6.39M Sell
60,288
-5,675
-9% -$628K 0.25% 95
2015
Q1
$7.53M Buy
65,963
+17,489
+36% +$2M 0.3% 23
2014
Q4
$5.34M Sell
48,474
-6,802
-12% -$717K 0.28% 39
2014
Q3
$5.4M Buy
+55,276
New +$5.44M 0.42% 39

Other funds holding ZBH

AHL Partners's ZBH Position: Q4 2017 in Review

AHL Partners increased its Zimmer Biomet (ZBH) stake by 46% in Q4 2017, buying an estimated $2.98M and bringing the position to 83,453 shares worth $9.78M. The position accounts for 0.15% of the portfolio, ranked #227.

AHL Partners first reported a position in ZBH in Q3 2014 and has held it in 13 quarters since. The position peaked at $11.5M in Q1 2017. 870 funds tracked by Wall St. Rank hold ZBH as of Q4 2017.

  • AHL Partners held 83,453 shares of Zimmer Biomet worth $9.78M as of Q4 2017.
  • AHL Partners bought 26,330 Zimmer Biomet shares in Q4 2017, an estimated $2.98M.
  • Zimmer Biomet made up 0.15% of AHL Partners's portfolio in Q4 2017, its #227 holding.
  • AHL Partners first reported a position in Zimmer Biomet in Q3 2014 and has held it in 13 quarters since.
  • AHL Partners's Zimmer Biomet position peaked at $11.5M in Q1 2017.
  • 870 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.